Galileo Research Facts No. 175: Do Galileo Therapy effects in the elderly last 6 months after end of intervention?

Galileo Research Facts No. 175: Do Galileo Therapy effects in the elderly last 6 months after end of intervention?

This study investigated the effects of Galileo Therapy on functional independence (Barthel Index) in frail elderly (age 74-90) Three groups: Control without intervention, Simulation (identical exercises without Galileo), Galileo group (26Hz, pos. 1-2, 20° squat, 5-10x 1min.,12 weeks, 3/week). Only the Galileo group showed significant improvements of 6% and could maintain them even 6 months after the end of intervention…

Galileo Research Facts No. 174: Can Galileo Therapy in COPD improve Balance more than Balance Training?

Galileo Research Facts No. 174: Can Galileo Therapy in COPD improve Balance more than Balance Training?

This study compared the effects of Galileo Therapy on balance in COPD patients (age 50-80) compared to traditional balance training. Galileo group: 4 exercises, 2x1min each, 5-26Hz, Pos.2-3, 3 weeks, 3/week, Controls: identical exercises on balance pad. Compared to control the Galileo group showed significant improvements in balance parameters of up to +23% after only 9 sessions over a period of 3 weeks…

Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?

Galileo Research Facts No. 172: Can Galileo Therapy increase Muscle Function in Interstitial Lung Diseases (ILD)?

This study investigated the effects of Galileo Therapy on muscle function (6MTW, CRT) in Interstitial Lung Diseases (ILD) (Age: 49-75). Galileo group: 30° squat, 3x3min, 26Hz, pos. 2-3, 16 weeks, 3/week, Control: identical exercises without Galileo. The Galileo group showed significant improvements in muscle function in 6MWT (+6%) and CRT (+13%) and at the same time an decrease in the inflammation parameter IL-6 (-33%)…

Galileo Research Facts No. 170: Can Galileo Therapy increase balance and muscle function also in frail elderly?

Galileo Research Facts No. 170: Can Galileo Therapy increase balance and muscle function also in frail elderly?

This study investigated the effects of Galileo Therapy on muscle function an balance in frail elderly (age 74-90) Three groups: Control without intervention, Simulation (identical exercises without Galileo), Galileo group (26Hz, pos. 1-2, 20° squat, 5-10x 1min.,12 weeks, 3/week). The Galileo group showed significant functional improvements of up to +14% while the other groups showed decrease in all parameters of up to -24%…

Galileo Research Facts No. 168: Is in Parkinson’s regeneration after Galileo Therapy faster than after treadmill therapy?

Galileo Research Facts No. 168: Is in Parkinson’s regeneration after Galileo Therapy faster than after treadmill therapy?

This study investigated the effects of treadmill therapy and Galileo Therapy in Parkinson’s patients on training intensity (oxygen uptake) as well as regeneration (4 weeks, 4/week: 4×5 min. walking vs. 10×1 Min Galileo, 26Hz, pos. 4, static semi squat). The Galileo group showed increased oxygen uptake (+41%) after 20 minutes but at the same time a significantly decreased regeneration time (EPOC, -37%)…

Galileo Research Facts No. 159: Can Galileo Therapy be used even under intense Chemotherapy in Leukemia?

Galileo Research Facts No. 159: Can Galileo Therapy be used even under intense Chemotherapy in Leukemia?

This safety study investigated the effects of Galileo Therapy during intense chemotherapy in Leukemia. Galileo Therapy was compared to cycling ergometer training (20 min., 18-25Hz, pos. 3-4, 120° squat, 3/week, 2 weeks). The Galileo group showed significant muscle function improvements compared to the ergometer group with in Chair-rise power (+4%), jump height (+12%) as well as timed up & go test (TUG, +19%)…

Galileo Research Facts No. 156: Can Galileo Therapy increase Bone Mass?

Galileo Research Facts No. 156: Can Galileo Therapy increase Bone Mass?

This study investigated possible positive effects of Hypoxia (simulated high-altitude training) on Galileo Therapy for the increase of bone mass in older individuals (age: 65-77). Three groups were used (Control, Galileo with & without Hypoxia, +5min. Ergometer warmup, 12.5Hz, 120° squat, pos. 2, 4x30sec, 2/week, 18 weeks). Both Galileo groups show significant improvements of bone mass compared with the control group…

Galileo Research Facts No. 155: Can Galileo Therapy help COVID-19 patients for therapy and physical rehab?

Galileo Research Facts No. 155: Can Galileo Therapy help COVID-19 patients for therapy and physical rehab?

The WAVex (World Association of Vibration Exercise Experts) Panel recommends the use of Galileo Therapy for COVID-19 patients for therapy and physical rehab. Background for the recommendation are the results of 36 international comparable studies – more than half of them using Galileo devices, including the import ones concerning the use in ICU, COPD, CP, Parkinson and allogeneic hematopoietic cell transplantation…

Galileo Research Facts No. 154: Can Galileo Therapy be used safely for patients in Intensive Care Units (ICU)?

Galileo Research Facts No. 154: Can Galileo Therapy be used safely for patients in Intensive Care Units (ICU)?

This study investigated effects and safety of Galileo application for mechanically ventilated patients in intensive care unit (UCI) with an expected stay of 7 days. A Galileo Med 15 was mounted directly to the ICU bed (exercises in lying, 3×3 Min., 24Hz, 20° knee flexion). The results showed significant positive muscular and cardiovascular effects and an improved muscle metabolism without negative side-effects…

Galileo Research Facts No. 153: Can Galileo Therapy help COVID-19 patients in Intensive Care Units (ICU)?

Galileo Research Facts No. 153: Can Galileo Therapy help COVID-19 patients in Intensive Care Units (ICU)?

The WAVex (World Association of Vibration Exercise Experts) Panel recommends the use of Galileo Therapy for COVID-19 patient therapy in Intensive Care Units (ICUs). Background are the results of 36 international comparable studies – more than half of them using Galileo devices, including the import ones concerning the use in ICU, COPD, CP, Parkinson and allogeneic hematopoietic cell transplantation…